Suzhou Chentai New Material Technology
Developing high-performance composite ceramics for medical application
About Suzhou Chentai New Material Technology
Suzhou Chentai New Material Technology, operating under the brand TrendTec, is a specialized enterprise focused on the development and production of high-performance composite ceramics for the medical sector. Established in January 2024, the company integrates research, design, manufacturing, and sales from its base in Suzhou. The firm operates two production facilities in the Suzhou High-tech Zone; the first phase covers 3,300 square meters, and a second 5,000-square-meter plant was added in 2024 to expand capacity. A key milestone was the completion of its first production line for zirconia-alumina composite ceramics in 2023, followed by a second line in 2024 designed to produce 300,000 units annually.
TrendTec's core business revolves around providing advanced ceramic materials to major orthopedic enterprises. The company's business model is vertically integrated, encompassing a dedicated R&D platform with over two decades of accumulated research, a performance testing platform to meet stringent medical standards, and a quality control system for commercial-scale production. Revenue is generated through the direct sale of its specialized ceramic components to medical device manufacturers. The company has developed a commercial sales platform to manage market outreach, channel partnerships, and international distribution.
The product portfolio is centered on bio-inert ceramics used in joint replacements. Key offerings include Zirconia-Toughened Alumina (ZTA) and yttria-stabilized tetragonal zirconia polycrystal (TZP) ceramic femoral heads. These materials are selected for their high strength, fracture toughness, and wear resistance, which are critical properties for orthopedic implants. The company's value proposition lies in its specialized focus and its established infrastructure for quality testing and large-scale manufacturing, positioning it as a key supplier in the medical components market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 20.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- medical implants, Composite Materials, Orthopedic, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Dec 2024 | $28M | $110M | Shanghai CICC Capital · Vivo Capital | ↗ |
Growth signals
Latest recorded traffic for Suzhou Chentai New Material Technology is 260 monthly website visits, up 420% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Eishita HealthtechIntraoral medical device correcting skeletal malocclusion |
Mangaluru, India | Operational | — | $244K | $978K |
High Fidelity OrthopaedicsAI-driven, patient-matched orthopaedic implants using 3D printing |
Australia | Operational | |||
Spark SpinePiezoelectric implants promoting accelerated orthopedic tissue regeneration |
United States | Operational | |||
| Chengdu, China | Operational | ||||
MedTech Solutions LLCPatented medical devices for sacroiliac joint pain, enhancing patient well-being with a holistic approach |
Germantown, United States | Operational | |||
| Kanazawa-shi, Japan | Operational | ||||
| Klamath Falls, United States | Operational | ||||
OPTIMOTION IMPLANTSTHE NEXT GENERATION TOTAL KNEE REPLACEMENT |
Orlando, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Suzhou Chentai New Material Technology in its local ecosystem
The Suzhou Chentai New Material Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Vivo Capital
Shanghai CICC Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Suzhou Chentai New Material Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Suzhou Chentai New Material Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






